BCL2 and neoplasm: Regarding NPC, we have recently shown that mRNA expression status of BCL2 is strongly associated with lymph node involvement and presence of distant metastases in patients, and that it may therefore represent a novel unfavorable and independent tumor biomarker of this malignancy [50].